Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1529-1555

  Touati, Arabella ^a,b   Peuchant, Olivia ^a,b,c   Jensen, Jorgen S ^d   Bébéar, Cécile ^a,b,c   Pereyrea, Sabine ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Univ Victor Segalen Bordeaux 2   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; RNA 23S; ANTIINFECTIVE AGENT; AZITHROMYCIN; BACTERIAL DNA;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; FRANCE; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN CELL; LIMIT OF DETECTION; MALE; MYCOPLASMA GENITALIUM; MYCOPLASMOSIS; NONHUMAN; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; MICROBIOLOGY; MYCOPLASMA INFECTIONS; PROCEDURES;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; FRANCE; HUMANS; MACROLIDES; MALE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; POINT MUTATION; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA;

EID: 84899540393     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03318-13     Document Type: Article

References (32)

1. Taylor-Robinson D, Jensen JS. 2011. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin. Microbiol. Rev. 24:498-514. http://dx.doi.org/10.1128/CMR.00006-11.
2. Haggerty CL. 2008. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr. Opin. Infect. Dis. 21:65-69. http://dx.doi.org/10. 1097/QCO.0b013e3282f3d9ac.
3. Jensen JS. 2004. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J. Eur. Acad. Dermatol. Venereol. 18:1-11. http://dx.doi.org/10.1111/j.1468-3083.2004.00923.x.
4. Cazanave C, Manhart LE, Bébéar C. 2012. Mycoplasma genitalium, an emerging sexually transmitted pathogen. Med. Mal. Infect. 42:381-392. http://dx.doi.org/10.1016/j.medmal.2012.05.006.
5. Le Roy C, Le Hen I, Clerc M, Arfel V, Normandin F, Bébéar C, de Barbeyrac B. 2012. The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. J. Microbiol. Methods 89:193-197. http://dx.doi.org/10.1016/j.mimet.2012.03.009.
6. Wroblewski JK, Manhart LE, Dickey KA, Hudspeth MK, Totten PA. 2006. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium. J. Clin. Microbiol. 44:3306-3312. http://dx.doi.org/10.1128/JCM.00553-06.
7. Mena LA, Mroczkowski TF, Nsuami M, Martin DH. 2009. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin. Infect. Dis. 48:1649-1654. http://dx.doi.org/10.1086/599033.
8. Chrisment D, Charron A, Cazanave C, Pereyre S, Bébéar C. 2012. Detection of macrolide resistance in Mycoplasma genitalium in France. J. Antimicrob. Chemother. 67:2598-2601. http://dx.doi.org/10.1093/jac/dks263.
9. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. 2008. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin. Infect. Dis. 47:1546-1553. http://dx.doi.org/10.1086/593188.
10. Twin J, Jensen JS, Bradshaw CS, Garland SM, Fairley CK, Min LY, Tabrizi SN. 2012. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS One 7:e35593. http://dx.doi.org/10.1371/journal.pone.0035593.
11. Jensen JS. 2012. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistancemediating mutations in region V of the 23S rRNA gene. Methods Mol. Biol. 903:129-139. http://dx.doi.org/10.1007/978-1-61779-937-2-8.
12. Yew HS, Anderson T, Coughlan E, Werno A. 2011. Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis. J. Clin. Microbiol. 49:1695-1696. http://dx.doi.org/ 10.1128/JCM.02475-10.
13. Bradshaw CS, Jensen JS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, Moss LM, Fairley CK. 2006. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg. Infect. Dis. 12:1149-1152. http://dx.doi.org/10.3201/eid1207.051558.
14. Gesink DC, Mulvad G, Montgomery-Andersen R, Poppel U, Montgomery-Andersen S, Binzer A, Vernich L, Frosst G, Stenz F, Rink E, Olsen OR, Koch A, Jensen JS. 2012. Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int. J. Circumpolar Health 71:1-8. http://dx.doi.org/10.3402/ijch.v71i0.18203.
15. Ito S, Shimada Y, Yamaguchi Y, Yasuda M, Yokoi S, Nakano M, Ishiko H, Deguchi T. 2011. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex. Transm. Infect. 87:412-414. http://dx.doi.org/10.1136/ sextrans-2011-050035.
16. Shimada Y, Deguchi T, Nakane K, Yasuda M, Yokoi S, Ito S, Nakano M, Ishiko H. 2011. Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. Emerg. Infect. Dis. 17:1148-1150. http://dx.doi.org/10.3201/ eid1706.101055.
17. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. 2008. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob. Agents Chemother. 52:3542-3549. http://dx.doi.org/10.1128/AAC.00582-08.
18. Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, Pereyre S. 2009. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother. 64:52-58. http://dx.doi.org/10.1093/jac/dkp160.
19. Spuesens EB, Meijer A, Bierschenk D, Hoogenboezem T, Donker GA, Hartwig NG, Koopmans MP, Vink C, van Rossum AM. 2012. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J. Clin. Microbiol. 50:1999-2004. http://dx.doi.org/10.1128/JCM.00400-12.
20. Hjorth SV, Bjornelius E, Lidbrink P, Falk L, Dohn B, Berthelsen L, Ma L, Martin DH, Jensen JS. 2006. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J. Clin. Microbiol. 44:2078-2083. http://dx.doi.org/10.1128/JCM.00003-06.
21. Jensen JS, Bjornelius E, Dohn B, Lidbrink P. 2004. Use of TaqMan 5= nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J. Clin. Microbiol. 42:683-692. http://dx.doi.org/ 10.1128/JCM.42.2.683-692.2004.
22. Tagg KA, Jeoffreys NJ, Couldwell DL, Donald JA, Gilbert GL. 2013. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J. Clin. Microbiol. 51:2245-2249. http://dx.doi.org/10.1128/JCM. 00495-13.
23. Hamasuna R. 2013. Identification of treatment strategies for Mycoplasma genitalium-related urethritis in male patients by culturing and antimicrobial susceptibility testing. J. Infect. Chemother. 19:1-11. http://dx.doi.org/10. 1007/s10156-012-0487-3.
24. Tong SY, Giffard PM. 2012. Microbiological applications of highresolution melting analysis. J. Clin. Microbiol. 50:3418-3421. http://dx.doi.org/10.1128/ JCM.01709-12.
25. Kannan K, Mankin AS. 2011. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Ann. N. Y. Acad. Sci. 1241:33-47. http://dx.doi.org/10.1111/j.1749-6632.2011.06315.x.
26. Bébéar C, Pereyre S, Peuchant O. 2011. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 6:423-431. http://dx.doi.org/10.2217/fmb.11.18.
27. Walker J, Fairley CK, Bradshaw CS, Tabrizi SN, Twin J, Chen MY, Taylor N, Donovan B, Kaldor JM, McNamee K, Urban E, Walker S, Currie M, Birden H, Bowden FJ, Gunn J, Pirotta M, Gurrin L, Harindra V, Garland SM, Hocking JS. 2013. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. Clin. Infect. Dis. 56:1094-1100. http://dx.doi.org/10.1093/cid/cis1210.
28. Jernberg E, Moghaddam A, Moi H. 2008. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int. J. STD AIDS 19:676-679. http://dx.doi.org/10.1258/ijsa.2008.008038.
29. Manhart LE, Broad JM, Golden MR. 2011. Mycoplasma genitalium: should we treat and how? Clin. Infect. Dis. 53(Suppl 3):S129-S142. http://dx.doi.org/10. 1093/cid/cir702.
30. Weinstein SA, Stiles BG. 2011. A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sex. Health 8:143-158. http://dx.doi.org/10.1071/SH10065.
31. Anagrius C, Lore B, Jensen JS. 2013. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 8:e61481. http://dx.doi.org/10. 1371/journal.pone.0061481.
32. Pond MJ, Nori AV, Witney AA, Lopeman RC, Butcher PD, Sadiq ST. 2014. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin. Infect. Dis. 58:631-637. http://dx.doi.org/10.1093/cid/cit752.